Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Aripiprazole as a Candidate Treatment of COVID-19 Identified Through Genomic Analysis

2 Mar 2021

Abstract excerpt

Background: Antipsychotics modulate expression of inflammatory cytokines and inducible inflammatory enzymes. Elopiprazole (a phenylpiperazine antipsychotic drug in phase 1) has been characterized as a therapeutic drug to treat SARS-CoV-2 infection in a repurposing study. We aim to investigate the potential effects of aripiprazole (an FDA approved phenylpiperazine) on COVID-19-related immunological parameters....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to COVID-19 Clinical Research Studies
Share to Long-Term Effects of COVID-19
Share to Tryptophan and brain disorders

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 33762960
DOI: 10.3389/fphar.2021.646701

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Aripiprazole as a Candidate Treatment of COVID-19 Identified Through Genomic AnalysisPMID 33762960Read ↗

Aripiprazole as a candidate treatment of COVID-19 identified through genomic analysisSemantic proximity Read ↗

COVID-19 patient transcriptomic and genomic profiling reveals comorbidity interactions with psychiatric disordersSemantic proximity Read ↗

Genetic analyses point to alterations in immune-related pathways underpinning the association between psychiatric disorders and COVID-19Semantic proximity Read ↗

Transcriptomic Analysis of the Peripheral Immune Cell of SARS-CoV-2 Infected Patients for Bridging the Genotype-Phenotype Gap and Drug Prediction: A Precision Medicine ApproachSemantic proximity Read ↗

Associations between brain gene expression perturbations implicated by COVID-19 and psychiatric disorders.Semantic proximity Read ↗

Transcriptomic analysis uncovers the shared and unique biological foundations acrossSchizophrenia, Bipolar and Major Depressive DisordersSemantic proximity Read ↗

Matrix metallopeptidase 9 as a host protein target of chloroquine and melatonin for immunoregulation in COVID-19: A network-based meta-analysisSemantic proximity Read ↗

A genetically based computational drug repurposing framework for rapid identification of candidate compounds: application to COVID-19Semantic proximity Read ↗

Discovery and Identification of Candidate Genes, Diagnostic Model and Drug Predictions for Schizophrenia and Crohn's Disease Through Integrated Bioinformatics Analysis and Machine LearningSemantic proximity Read ↗

The role of antipsychotics and other drugs on the development and progression of Neuroleptic Malignant SyndromeSemantic proximity Read ↗

Association of intestinal anti-inflammatory drug target genes with psychiatric Disorders: A Mendelian randomization study.Semantic proximity Read ↗

Published Anti-SARS-CoV-2 In Vitro Hits Share Common Mechanisms of Action that Synergize with AntiviralsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.